22 July 2024
Sofia, Bulgaria, July 22, 2024 – According to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for June 2024 the Company recorded a decrease in sales of 35% compared to the same month of the previous year, incl. 7% decrease in domestic sales and 49% decrease in export sales.
For the first six months of 2024, the Company recorded a decrease in sales of 8%, incl. 4% increase of domestic sales and 15% decrease in export sales.